Skip to main navigation Skip to search Skip to main content

Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes

  • Susan van Dieren
  • , Andre-Pascal Kengne
  • , John P Chalmers
  • , Joline W J Beulens
  • , Mark Emmanuel Cooper
  • , Diederick E Grobbee
  • , Stephen B Harrap
  • , Giuseppe Mancia
  • , Bruce Neal
  • , Anushka Patel
  • , Neil Poulter
  • , Yvonne T van der Schouw
  • , Mark Woodward
  • , Sophia Zoungas

Research output: Contribution to journalArticleResearchpeer-review

Abstract

To asses differences in treatment effects of a fixed combination of perindopril-indapamide on major clinical outcomes in patients with type 2 diabetes across subgroups of cardiovascular risk.
Original languageEnglish
Pages (from-to)83 - 90
Number of pages8
JournalDiabetes Research and Clinical Practice
Volume98
Issue number1
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ADVANCE trial
  • Blood pressure
  • Diabetes mellitus
  • Cardiovascular disease
  • Coronary heart disease
  • Framingham
  • Mortality
  • Risk groups
  • Risk scores
  • Type 2 diabetes

Cite this